Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MEF2D |
| Upstream (Parents) |
|---|
| (<<) CFL1 → MEF2D |
| (<<) CIRH1A → MEF2D |
| (<<) DDX18 → MEF2D |
| (<<) DUSP7 → MEF2D |
| (<<) EIF6 → MEF2D |
| (<<) ITGB5 → MEF2D |
| (<<) LRP5 → MEF2D |
| (<<) MAP3K7 → MEF2D |
| (<<) PAK1 → MEF2D |
| (<<) PLEKHF1 → MEF2D |
| (<<) PPP3CC → MEF2D |
| (<<) PTPMT1 → MEF2D |
| (<<) SEH1L → MEF2D |
| (<<) STAT2 → MEF2D |
| (<<) THOC4 → MEF2D |
| (<<) TK2 → MEF2D |
| (<<) UBE2J1 → MEF2D |
| Downstream (Children) |
|---|
| MEF2D → ATN1 (>>) |
| MEF2D → BCAR3 (>>) |
| MEF2D → CACNA1E (>>) |
| MEF2D → CACNA1I (>>) |
| MEF2D → CBFA2T3 (>>) |
| MEF2D → CCDC88A (>>) |
| MEF2D → CDR2 (>>) |
| MEF2D → ENTPD7 (>>) |
| MEF2D → HSP90AA1 (>>) |
| MEF2D → HSPA5 (>>) |
| MEF2D → HSPC159 (>>) |
| MEF2D → KRTAP4-1 (>>) |
| MEF2D → MIA3 (>>) |
| MEF2D → PIK3C2B (>>) |
| MEF2D → RPA4 (>>) |
| MEF2D → RRAS2 (>>) |
| MEF2D → SIN3A (>>) |
| MEF2D → TARS (>>) |
| MEF2D → TUBA1A (>>) |
| MEF2D → UBE2I (>>) |
